BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 22497632)

  • 21. Validation of the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation in advanced chronic renal failure.
    Teruel Briones JL; Gomis Couto A; Sabater J; Fernández Lucas M; Rodríguez Mendiola N; Villafruela JJ; Quereda C
    Nefrologia; 2011; 31(6):677-82. PubMed ID: 22130283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of associations of outcomes after stroke with estimated GFR using Chinese modifications of the MDRD study and CKD-EPI creatinine equations: results from the China National Stroke Registry.
    Wang X; Luo Y; Wang Y; Wang C; Zhao X; Wang D; Liu L; Liu G; Wang Y;
    Am J Kidney Dis; 2014 Jan; 63(1):59-67. PubMed ID: 24100127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implication of CKD-EPI equation to estimate glomerular filtration rate in Chinese patients with chronic kidney disease.
    Du X; Hu B; Jiang L; Wan X; Fan L; Wang F; Cao C
    Ren Fail; 2011; 33(9):859-65. PubMed ID: 21851197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma.
    Ni JY; Sun HL; Chen YT; Luo JH; Chen D; Jiang XY; Xu LF
    World J Gastroenterol; 2014 Dec; 20(46):17483-90. PubMed ID: 25516662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemoembolization for hepatocellular carcinoma: multivariate analysis of predicting factors for tumor response and survival in a 362-patient cohort.
    Hu HT; Kim JH; Lee LS; Kim KA; Ko GY; Yoon HK; Sung KB; Gwon DI; Shin JH; Song HY
    J Vasc Interv Radiol; 2011 Jul; 22(7):917-23. PubMed ID: 21571545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood neutrophil-to-lymphocyte ratio predicts survival in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization.
    Huang ZL; Luo J; Chen MS; Li JQ; Shi M
    J Vasc Interv Radiol; 2011 May; 22(5):702-9. PubMed ID: 21514523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of routine reporting of estimated glomerular filtration rate using the CKD-EPI formula in a community population: A cross-sectional cohort study.
    Mitchell T; Hadlow N; Chakera A
    Nephrology (Carlton); 2014 Sep; 19(9):581-6. PubMed ID: 24888643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppressive effects of entecavir on hepatitis B virus and hepatocellular carcinoma.
    Jin YJ; Shim JH; Lee HC; Yoo DJ; Kim KM; Lim YS; Suh DJ
    J Gastroenterol Hepatol; 2011 Sep; 26(9):1380-8. PubMed ID: 21884247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of surgical resection and transarterial chemoembolization for hepatocellular carcinoma beyond the Milan criteria: a propensity score analysis.
    Hsu CY; Hsia CY; Huang YH; Su CW; Lin HC; Pai JT; Loong CC; Chiou YY; Lee RC; Lee FY; Huo TI; Lee SD
    Ann Surg Oncol; 2012 Mar; 19(3):842-9. PubMed ID: 21913008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of Risk Prediction With the CKD-EPI and MDRD Equations in Non-ST-Segment Elevation Acute Coronary Syndrome.
    Flores-Blanco PJ; López-Cuenca Á; Januzzi JL; Marín F; Sánchez-Martínez M; Quintana-Giner M; Romero-Aniorte AI; Valdés M; Manzano-Fernández S
    Clin Cardiol; 2016 Sep; 39(9):507-15. PubMed ID: 27249221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence and risk factors for acute renal failure in patients with hepatocellular carcinoma undergoing transarterial chemoembolization: a prospective study.
    Huo TI; Wu JC; Lee PC; Chang FY; Lee SD
    Liver Int; 2004 Jun; 24(3):210-5. PubMed ID: 15189271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The validation of estimated glomerular filtration rate (eGFR) equation for renal transplant recipients.
    Townamchai N; Praditpornsilpa K; Chawatanarat T; Avihingsanon Y; Tiranathanagul K; Katavetin P; Susantitaphong P; Kanjanabuch T; Tungsanga K; Eiam-Ong S
    Clin Nephrol; 2013 Mar; 79(3):206-13. PubMed ID: 23073069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal function in heart failure: a disparity between estimating function and predicting mortality risk.
    Plischke M; Neuhold S; Kohl M; Heinze G; Sunder-Plassmann G; Pacher R; Hülsmann M
    Eur J Heart Fail; 2013 Jul; 15(7):763-70. PubMed ID: 23429976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transarterial chemoembolization for hepatocellular carcinoma: development and external validation of the Munich-TACE score.
    Op den Winkel M; Nagel D; Op den Winkel P; Trojan J; Paprottka PM; Steib CJ; Schmidt L; Göller M; Stieber P; Göhring P; Herbst A; Rentsch M; De Toni EN; Göke B; Gerbes AL; Kolligs FT
    Eur J Gastroenterol Hepatol; 2018 Jan; 30(1):44-53. PubMed ID: 29076939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimating glomerular filtration rate (GFR) in diabetes: the performance of MDRD and CKD-EPI equations in patients with various degrees of albuminuria.
    Vučić Lovrenčić M; Radišić Biljak V; Božičević S; Prašek M; Pavković P; Knotek M
    Clin Biochem; 2012 Dec; 45(18):1694-6. PubMed ID: 22968085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transarterial chemoembolization in patients with hepatocellular carcinoma and renal insufficiency.
    Hsu CY; Huang YH; Su CW; Chiang JH; Lin HC; Lee PC; Lee FY; Huo TI; Lee SD
    J Clin Gastroenterol; 2010 Sep; 44(8):e171-7. PubMed ID: 20048685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study.
    Yamagiwa K; Shiraki K; Yamakado K; Mizuno S; Hori T; Yagi S; Hamada T; Iida T; Nakamura I; Fujii K; Usui M; Isaji S; Ito K; Tagawa S; Takeda K; Yokoi H; Noguchi T
    J Gastroenterol Hepatol; 2008 Mar; 23(3):482-90. PubMed ID: 18086115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of alpha-fetoprotein status in the outcome of hepatocellular carcinoma after treatment of transarterial chemoembolization.
    Wang Y; Chen Y; Ge N; Zhang L; Xie X; Zhang J; Chen R; Wang Y; Zhang B; Xia J; Gan Y; Ren Z; Ye S
    Ann Surg Oncol; 2012 Oct; 19(11):3540-6. PubMed ID: 22532305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
    Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammation scores predict survival for hepatitis B virus-related hepatocellular carcinoma patients after transarterial chemoembolization.
    Zhou DS; Xu L; Luo YL; He FY; Huang JT; Zhang YJ; Chen MS
    World J Gastroenterol; 2015 May; 21(18):5582-90. PubMed ID: 25987783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.